UBcare. Co., Ltd. (KOSDAQ:032620)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,055.00
+30.00 (0.75%)
At close: Aug 7, 2025, 3:30 PM KST
0.75%
Market Cap205.51B
Revenue (ttm)190.40B
Net Income (ttm)1.17B
Shares Out50.74M
EPS (ttm)23.09
PE Ratio175.43
Forward PEn/a
Dividend30.00 (0.74%)
Ex-Dividend DateDec 27, 2024
Volume210,644
Average Volume392,218
Open4,020.00
Previous Close4,025.00
Day's Range3,990.00 - 4,055.00
52-Week Range3,045.00 - 5,220.00
Beta0.78
RSI61.30
Earnings DateAug 14, 2025

About Verve Therapeutics

UBcare. Co., Ltd., together with its subsidiaries, provides electronic medical record solutions for hospitals, clinics, and pharmacies in South Korea and the United States. It operates through Medical Information Platform - EMR; Medical Information Platform – Circulation; Medical Information Platform – Data; and Manufacturing segments. The company offers integrated hospital/clinic management solutions; mobile patient management solutions; medical waiting media solutions; solutions for automated inspection request and result inquiry; solutions t... [Read more]

Industry Prepackaged Software
Founded 1992
Employees 302
Stock Exchange KOSDAQ
Ticker Symbol 032620
Full Company Profile

Financial Performance

In 2024, UBcare.'s revenue was 190.60 billion, an increase of 23.73% compared to the previous year's 154.04 billion. Losses were -1.59 billion, -7.33% less than in 2023.

Financial Statements

News

There is no news available yet.